Symphony Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Symphony Asset Management's AMGN Position: Q3 2019 in Review
Symphony Asset Management sold out of Amgen (AMGN) in Q3 2019, closing a stake of 2,013 shares — an estimated $371K sold.
Symphony Asset Management first reported a position in AMGN in Q2 2013 and held it in 22 quarters. The position peaked at $4.65M in Q2 2015. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.
- Symphony Asset Management reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
- Symphony Asset Management sold 2,013 Amgen shares in Q3 2019, an estimated $371K.
- Symphony Asset Management first reported a position in Amgen in Q2 2013 and held it in 22 quarters.
- Symphony Asset Management's Amgen position peaked at $4.65M in Q2 2015.
- 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.
Based on Symphony Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.